International Diabetes News
Dementia-like clumps found in cells before cancer strikes
Cancer Research UK-funded scientists have uncovered dementia-like behavior in pancreas cells at risk of turning into cancer. The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a difficult-to-treat disease linked to 6,900 deaths in the UK every year.*
National registry launched to transform care for people at risk of type 1 diabetes
The UK Islet Autoantibody Registry aims to transform how people in the early ‘hidden’ stages of type 1 diabetes are monitored and supported, and act as a gateway to ground-breaking clinical trials and treatments. The registry – led by Dr Rachel Besser – will track children and adults who have tested positive for type 1 diabetes autoantibodies.
Diabetes Tied to Doubled Risk for Sepsis
Hypoglycaemia Rates Drop for Pancreatic Diabetes in Denmark
In a nationwide cohort study of patients with newly diagnosed diabetes, hospitalisations for severe hypoglycaemia among those with pancreatic diabetes dropped significantly from 2003-2006 to 2019-2022. Shifts in treatment patterns, including the increased use of metformin and the transition from human insulin to analogues, likely contributed to this substantial decline, although patients with pancreatic diabetes remained at a notable risk for hypoglycaemia
Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications
With the advent of novel glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, and the discovery of their protective benefit against both adverse cardiovascular and kidney outcomes in large randomized clinical trials (RCTs), there has been intense interest in prescribing these agents for a large proportion of the population. However, it is still unclear through what causal mechanism these benefits may occur.
Clinical Trials
You can search for some available information on clinical trials